等待开盘 10-10 09:30:00 美东时间
-6.640
-3.70%
2025年9月27日,亚利桑那州凤凰城,英特尔Tech Tour(ITT)活动现场,新一代客户端处理器Panther Lake正式亮相。这款产品在架构设计、能效...
今天 00:38
Skye Bioscience'a trial showed nimacimab alone missed goals, while a combo with Novo Nordisk's drug delivered stronger weight loss results.
10-06 22:39
今日重点评级关注:Maxim Group:维持Kazia Therapeutics"买入"评级,目标价从15美元升至20美元;Baird:维持Taysha Gene Therapies"跑赢大市"评级,目标价从7美元升至12美元
10-03 14:32
Analysts' ratings for ITT (NYSE:ITT) over the last quarter vary from bullish to...
10-03 03:00
TD Cowen analyst Joseph Giordano maintains ITT (NYSE:ITT) with a Buy and raises the price target from $170 to $190.
10-02 22:08
瑞士制药商罗氏(RHHBY.US)的一项后期试验中,实验性药物 giredestrant 帮助患有特定类型晚期乳腺癌的患者延长了疾病未恶化的生存期。
09-22 17:20
evERA met its co-primary endpoints; giredestrant plus everolimus demonstrated significant benefit in ITT and ESR1-mutated populations in the post-CDK inhibitor setting, compared with standard of care plus
09-22 14:27
今日重点评级关注:HC Wainwright & Co.:维持Orion Energy Sys"买入"评级,目标价从2美元升至20美元;高盛:维持Amylyx Pharmaceuticals"买入"评级,目标价从10美元升至20美元
09-17 10:15
公司名称
|
ITT
|
行业分类
|
工业机械
|
业务描述
|
ITT, Inc. engages in the manufacture and sale of engineered components and customized technology solutions primarily for the transportation, industrial, and energy markets. It operates through the following segments: Motion Technologies (MT), Industrial Process (IP), and Connect and Control Technologies (CCT). The MT segment includes ITT Friction Technologies, Axtone, KONI, Novitek, Wolverine Advanced Materials, and GALT brands. The IP segment refers to Goulds Pumps, PRO Services, Rheinh tte Pumpen, Bornemann, C'treat, Habonim, Engineered Valves, and i-ALERT brands. The CCT segment is involved in the Cannon, Aerospace Controls, Neo-Dyn, VEAM, Enidine, Conoflow, BIW Connector Systems, Compact Automation, and Micro-Mode brands. The company was founded in 1920 and is headquartered in Stamford, CT.
|
2025年9月27日,亚利桑那州凤凰城,英特尔Tech Tour(ITT)活动现场,新一代客户端处理器Panther Lake正式亮相。这款产品在架构设计、能效...
今天 00:38
Skye Bioscience'a trial showed nimacimab alone missed goals, while a combo with Novo Nordisk's drug delivered stronger weight loss results.
10-06 22:39
今日重点评级关注:Maxim Group:维持Kazia Therapeutics"买入"评级,目标价从15美元升至20美元;Baird:维持Taysha Gene Therapies"跑赢大市"评级,目标价从7美元升至12美元
10-03 14:32
Analysts' ratings for ITT (NYSE:ITT) over the last quarter vary from bullish to...
10-03 03:00
TD Cowen analyst Joseph Giordano maintains ITT (NYSE:ITT) with a Buy and raises the price target from $170 to $190.
10-02 22:08
瑞士制药商罗氏(RHHBY.US)的一项后期试验中,实验性药物 giredestrant 帮助患有特定类型晚期乳腺癌的患者延长了疾病未恶化的生存期。
09-22 17:20
evERA met its co-primary endpoints; giredestrant plus everolimus demonstrated significant benefit in ITT and ESR1-mutated populations in the post-CDK inhibitor setting, compared with standard of care plus
09-22 14:27
今日重点评级关注:HC Wainwright & Co.:维持Orion Energy Sys"买入"评级,目标价从2美元升至20美元;高盛:维持Amylyx Pharmaceuticals"买入"评级,目标价从10美元升至20美元
09-17 10:15
派息除权日
|
每股总股息
| 派息日期 |
2025-09-02
|
0.35
|
2025-09-29
|
2025-06-02
|
0.35
|
2025-06-30
|
2025-03-06
|
0.35
|
2025-03-31
|
2024-11-29
|
0.32
|
2024-12-31
|
2024-09-03
|
0.32
|
2024-09-30
|
2024-06-03
|
0.32
|
2024-07-01
|
2024-03-07
|
0.32
|
2024-04-01
|
2023-11-30
|
0.29
|
2023-12-29
|
2023-08-31
|
0.29
|
2023-10-02
|
2023-06-08
|
0.29
|
2023-07-03
|
2023-03-08
|
0.29
|
2023-04-03
|
2022-11-30
|
0.26
|
2022-12-30
|
2022-09-01
|
0.26
|
2022-10-03
|
2022-06-16
|
0.26
|
2022-07-05
|
2022-03-08
|
0.26
|
2022-04-04
|
2021-12-10
|
0.22
|
2021-12-30
|
2021-09-10
|
0.22
|
2021-10-04
|
2021-06-18
|
0.22
|
2021-07-06
|
2021-03-16
|
0.22
|
2021-04-05
|
2020-12-04
|
0.17
|
2020-12-30
|
2020-09-10
|
0.17
|
2020-10-05
|
2020-06-12
|
0.17
|
2020-07-06
|
2020-03-13
|
0.17
|
2020-04-06
|
2019-12-06
|
0.15
|
2019-12-30
|
2019-09-09
|
0.15
|
2019-10-01
|
2019-06-07
|
0.15
|
2019-07-01
|
2019-03-08
|
0.15
|
2019-04-01
|
2018-12-06
|
0.13
|
2018-12-28
|
2018-09-07
|
0.13
|
2018-10-01
|
2018-06-08
|
0.13
|
2018-07-02
|
2018-03-09
|
0.13
|
2018-04-02
|
2017-12-07
|
0.13
|
2017-12-29
|
2017-09-08
|
0.13
|
2017-10-02
|
2017-06-08
|
0.13
|
2017-07-03
|
2017-03-09
|
0.13
|
2017-04-03
|
2016-12-07
|
0.12
|
2016-12-30
|
2016-09-07
|
0.12
|
2016-10-03
|
2016-06-08
|
0.12
|
2016-07-01
|
2016-03-09
|
0.12
|
2016-04-01
|
2015-12-09
|
0.12
|
2015-12-31
|
2015-09-09
|
0.12
|
2015-10-01
|
2015-06-10
|
0.12
|
2015-07-01
|
2015-03-11
|
0.12
|
2015-04-01
|
2014-12-10
|
0.11
|
2014-12-31
|
2014-09-10
|
0.11
|
2014-10-01
|
2014-06-11
|
0.11
|
2014-07-01
|
2014-03-12
|
0.11
|
2014-04-01
|
2013-11-13
|
0.10
|
2013-12-31
|
2013-08-28
|
0.10
|
2013-10-01
|
2013-05-22
|
0.10
|
2013-07-01
|
2013-03-13
|
0.10
|
2013-04-01
|
2012-11-15
|
0.09
|
2012-12-31
|
2012-08-29
|
0.09
|
2012-10-01
|
2012-05-23
|
0.09
|
2012-07-01
|
2012-03-05
|
0.09
|
2012-04-01
|
2011-11-08
|
0.09
|
2011-12-31
|
2011-08-24
|
0.25
|
2011-10-01
|
2011-05-18
|
0.25
|
2011-07-01
|
2011-02-28
|
0.25
|
2011-04-01
|
2010-11-09
|
0.25
|
2011-01-01
|
2010-08-25
|
0.25
|
2010-10-01
|
2010-05-19
|
0.25
|
2010-07-01
|
2010-03-01
|
0.25
|
2010-04-01
|
2009-11-10
|
0.21
|
2010-01-01
|
2009-08-19
|
0.21
|
2009-10-01
|
2009-05-20
|
0.21
|
2009-07-01
|
2009-03-02
|
0.21
|
2009-04-01
|
2008-11-12
|
0.17
|
2009-01-01
|
2008-08-20
|
0.17
|
2008-10-01
|
2008-05-21
|
0.17
|
2008-07-01
|
2008-03-05
|
0.17
|
2008-04-01
|
2007-11-14
|
0.14
|
2008-01-01
|
2007-08-22
|
0.14
|
2007-10-01
|
2007-05-16
|
0.14
|
2007-07-01
|
2007-03-07
|
0.14
|
2007-04-01
|
2006-11-15
|
0.11
|
2007-01-01
|
2006-08-23
|
0.11
|
2006-10-01
|
2006-05-17
|
0.11
|
2006-07-01
|
2006-03-08
|
0.11
|
2006-04-01
|
2005-11-16
|
0.18
|
2006-01-01
|
2005-08-24
|
0.18
|
2005-10-01
|
2005-05-18
|
0.18
|
2005-07-01
|
2005-03-09
|
0.18
|
2005-04-01
|
2004-11-17
|
0.17
|
2005-01-01
|
2004-08-25
|
0.17
|
2004-10-01
|
2004-05-19
|
0.17
|
2004-07-01
|
2004-03-10
|
0.17
|
2004-04-01
|
2003-11-19
|
0.16
|
2004-01-01
|
2003-08-27
|
0.16
|
2003-10-01
|
2003-05-21
|
0.16
|
2003-07-01
|
2003-03-12
|
0.16
|
2003-04-01
|
2002-11-20
|
0.15
|
2003-01-01
|
2002-08-28
|
0.15
|
2002-10-01
|
2002-05-22
|
0.15
|
2002-07-01
|
2002-03-13
|
0.15
|
2002-04-01
|
2001-11-28
|
0.15
|
2002-01-01
|
2001-08-29
|
0.15
|
2001-10-01
|
2001-05-23
|
0.15
|
2001-07-01
|
2001-03-14
|
0.15
|
2001-04-01
|
2000-11-20
|
0.15
|
2001-01-01
|
2000-08-23
|
0.15
|
2000-10-01
|
2000-05-24
|
0.15
|
2000-07-01
|
2000-02-23
|
0.15
|
2000-04-01
|
1999-11-22
|
0.15
|
2000-01-01
|
1999-08-25
|
0.15
|
1999-10-01
|
1999-05-26
|
0.15
|
1999-07-01
|
1999-02-24
|
0.15
|
1999-04-01
|
1998-11-23
|
0.15
|
1999-01-01
|
1998-08-26
|
0.15
|
1998-10-01
|
1998-05-27
|
0.15
|
1998-07-01
|
1998-05-26
|
0.15
|
1998-07-01
|
1998-02-25
|
0.15
|
1998-04-01
|
1997-11-25
|
0.15
|
1998-01-01
|
1997-08-27
|
0.15
|
1997-10-01
|
1997-05-28
|
0.15
|
1997-07-01
|
1997-02-26
|
0.15
|
1997-04-01
|
1996-11-13
|
0.15
|
1997-01-01
|
1996-08-07
|
0.15
|
1996-10-01
|
1996-05-15
|
0.15
|
1996-07-01
|
1996-02-21
|
0.15
|
1996-04-01
|
1994-07-01
|
0.10
|
1994-07-01
|
1994-04-05
|
0.09
|
1994-04-01
|
1994-01-03
|
0.08
|
1994-01-01
|
1993-10-01
|
0.08
|
1993-10-01
|
1993-07-01
|
0.08
|
1993-07-01
|
1993-04-01
|
0.09
|
1993-04-01
|
1993-01-04
|
0.08
|
1993-01-01
|
1992-10-01
|
0.09
|
1992-10-01
|
1992-07-01
|
0.09
|
1992-07-01
|
1992-04-01
|
0.08
|
1992-04-01
|
1992-01-02
|
0.08
|
1992-01-01
|
1991-10-01
|
0.07
|
1991-10-01
|
1991-07-01
|
0.07
|
1991-07-01
|
1991-04-02
|
0.07
|
1991-04-01
|
1991-01-02
|
0.08
|
1991-01-01
|
1990-10-01
|
0.07
|
1990-10-01
|
1990-07-02
|
0.07
|
1990-07-02
|
1990-04-02
|
0.07
|
1990-04-01
|
1990-01-02
|
0.07
|
1990-01-01
|
1989-10-01
|
0.06
|
1989-10-01
|
1989-07-01
|
0.05
|
1989-07-01
|
1989-04-01
|
0.06
|
1989-04-01
|
1989-01-01
|
0.06
|
1989-01-01
|